A smart dry-powder inhaler for children, developed by Israeli mechanical engineer Nimrod Kaufmann with Dr. Guy Steuer, senior pulmonologist at Schneider Children’s Medical Center in Petah Tikvah, just completed a successful clinical trial at Schneider.
Inspiromatic is produced by Inspiro Medical, a portfolio company of The Trendlines Group, and is meant to take the place of hard-to-use nebulizers for young children as well as the elderly and people with certain disabilities.
Kaufmann, who came from a background in medical devices research and development, knew that dry-powder inhalers do a better, faster job with less risk of error and contamination, but kids in particular can’t use them properly.
Inspiromatic has an internal microcontroller and flow sensor that detects the right time to deliver the medication and automatically disperse the drug particles in the right size without need for forceful inhalation.
The randomized, crossover, double-blind study aimed to objectively assess the efficacy and safety of Inspiromatic in delivering bronchodilator meds to 30 children with asthma, aged 8-18, compared to a competitive inhaler already on the market.
According to a company statement, the results demonstrated superior results for the Inspiromatic, even in patients with poor inhalation technique, and it was highly rated by patients for ease of use.
“This successful study will enable us to move to the next step in the company development and partner with pharmaceutical companies to develop drug-device combinations and also bring better therapy to patients with poor inhalation technique,” said Kaufmann.